greeksoup/ stock research

Universal Health Services (UHS) FY2023 results: revenue $14.3 billion, up 6.6% on the year

Universal Health Services Inc. (UHS) reported revenue of $14.3 billion for fiscal 2023, the year ended 31 December 2023, up 6.6% on the year before. Net income was $718 million, up 6.2%, and diluted earnings per share $10.23. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2024.

Revenue
$14.3 billion
+6.6% on the year
FY2016FY2023
Operating margin
8.2%
7.5% a year earlier
FY2016FY2023
Net income
$718 million
+6.2% on the year
FY2016FY2023
Diluted EPS
$10.23
+11.9% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue14,28213,39912,642+6.6%
Operating income1,1751,0041,363+17.1%
Operating margin8.2%7.5%10.8%
Interest expense20712783.7+62.9%
Pre-tax income9408661,293+8.6%
Income tax221209306+5.7%
Effective tax rate23.5%24.2%23.6%
Net income718676992+6.2%
Net margin5.0%5.0%7.8%
Diluted EPS$10.23$9.14$11.82+11.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow1,268996884+27.3%
Capital expenditure743734856+1.2%
Free cash flow52526228.0+100.3%
Free cash flow margin3.7%2.0%0.2%
Cash from investing-763-647-914
Cash from financing-494-318-1,069
Depreciation and amortisation568582533-2.4%
Share-based compensation87.785.473.7+2.7%
Buybacks5478331,221-34.3%
Dividends paid55.558.465.9-5.1%
Dividend per share$0.80$0.80$0.800.0%
Diluted shares, weighted70m74m84m-5.0%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity6,1495,9216,090+3.9%
Non-controlling interest47.744.8103+6.6%
Redeemable equity5.24.75.1+10.6%
Debt4,9124,8084,190+2.2%
Operating lease liabilities383396305-3.3%
Finance lease liabilities69.672.576.6-4.0%
Other liabilities2,4012,2482,324+6.8%
Total liabilities and equity13,96813,49413,094+3.5%
Fixed assets6,1255,9185,874+3.5%
Goodwill3,9323,9093,963+0.6%
Intangible assets77.078.181.0-1.4%
Cash and equivalents119103115+16.2%
Receivables2,2382,0181,747+10.9%
Other assets1,4761,4681,314+0.6%
Total assets13,96813,49413,094+3.5%

10-K for the year ended 31 December 2023, filed 27 February 2024: the filing.